The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fedorova N.V.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Kulua T.K.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Gubanova Е.N.

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia;
Center of Extrapyramidal Disorders, Moscow

The use of piribedil in early and late stages of Parkinson’s disease

Authors:

Fedorova N.V., Kulua T.K., Gubanova Е.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(10): 96‑98

DOI: 10.17116/jnevro201511510196-98

Read: 6426 times

Contact the author
Table of contents

THE USE OF PIRIBEDIL IN EARLY AND LATE STAGES OF PARKINSON’S DISEASE
THE USE OF PIRIBEDIL IN EARLY AND LATE STAGES OF PARKINSON’S DISEASE

To cite this article:

Fedorova NV, Kulua TK, Gubanova ЕN. The use of piribedil in early and late stages of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(10):96‑98. (In Russ.)
https://doi.org/10.17116/jnevro201511510196-98

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14
Cardiogenic deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):43-49
Change of speech diso­rders during bila­teral deep stimulation of the subthalamic nucleus of the brain in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):59-65
Comparative study of the neuroprotective effe­cts of the drug Cyto­flavin and citi­coline in a rats model of hemo­rrhagic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):85-95
Diagnosis of Alzheimer’s disease using biological markers in corticobasal syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):133-139
Effe­ctiveness of “brain—computer” inte­rfaces with biofeedback in the reha­bilitation of cognitive impairment after a stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):54-60
Pote­ntial and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medi­cine. 2025;(7):94-99
Cognitive reha­bilitation technology using a combination of postural training and simu­ltaneous cognitive task in prevention of cognitive impairment after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):418-427
The impact of Mexi­dol on improving quality of life para­meters and functional kidney status as part of complex therapy for cognitive impairments in como­rbid patients with microalbuminuria against the background of arte­rial hype­rtension and type 2 diabetes mellitus. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):478-478
Dyna­mics of permeability of the blood-brain barrier after FUS thalamotomy acco­rding to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60
Abstract:

In this article, we present clinical cases at an early stage of Parkinson’s disease with mild affective and cognitive disorders, and at a later stage with motor fluctuations and levodopa-induced dyskinesia. The efficacy of dopamine receptor agonists in treatment of Parkinson’s disease in the early and late stages is illustrated by the example of piribedil.

Keywords:

dopamine receptor agonists
piribedil
Parkinson’s disease
cognitive disorders
affective disorders
levodopa-induced dyskinesias

Authors:

Fedorova N.V.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Kulua T.K.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Gubanova Е.N.

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia;
Center of Extrapyramidal Disorders, Moscow

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.